DOT1L
Histone-lysine N-methyltransferase, H3 lysine-79 specific
Also known as: DOT1, DOT1L_HUMAN, KIAA1814, KMT4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TEK3
- Gene
- DOT1L
- Ensembl
- ENSG00000104885
- Chromosome
- 19
- Canonical length
- 1537 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
1537 residues, UniProt reviewed canonical sequence.
>Q8TEK3|DOT1L
1 MGEKLELRLK SPVGAEPAVY PWPLPVYDKH HDAAHEIIET IRWVCEEIPD LKLAMENYVL
61 IDYDTKSFES MQRLCDKYNR AIDSIHQLWK GTTQPMKLNT RPSTGLLRHI LQQVYNHSVT
121 DPEKLNNYEP FSPEVYGETS FDLVAQMIDE IKMTDDDLFV DLGSGVGQVV LQVAAATNCK
181 HHYGVEKADI PAKYAETMDR EFRKWMKWYG KKHAEYTLER GDFLSEEWRE RIANTSVIFV
241 NNFAFGPEVD HQLKERFANM KEGGRIVSSK PFAPLNFRIN SRNLSDIGTI MRVVELSPLK
301 GSVSWTGKPV SYYLHTIDRT ILENYFSSLK NPKLREEQEA ARRRQQRESK SNAATPTKGP
361 EGKVAGPADA PMDSGAEEEK AGAATVKKPS PSKARKKKLN KKGRKMAGRK RGRPKKMNTA
421 NPERKPKKNQ TALDALHAQT VSQTAASSPQ DAYRSPHSPF YQLPPSVQRH SPNPLLVAPT
481 PPALQKLLES FKIQYLQFLA YTKTPQYKAS LQELLGQEKE KNAQLLGAAQ QLLSHCQAQK
541 EEIRRLFQQK LDELGVKALT YNDLIQAQKE ISAHNQQLRE QSEQLEQDNR ALRGQSLQLL
601 KARCEELQLD WATLSLEKLL KEKQALKSQI SEKQRHCLEL QISIVELEKS QRQQELLQLK
661 SCVPPDDALS LHLRGKGALG RELEPDASRL HLELDCTKFS LPHLSSMSPE LSMNGQAAGY
721 ELCGVLSRPS SKQNTPQYLA SPLDQEVVPC TPSHVGRPRL EKLSGLAAPD YTRLSPAKIV
781 LRRHLSQDHT VPGRPAASEL HSRAEHTKEN GLPYQSPSVP GSMKLSPQDP RPLSPGALQL
841 AGEKSSEKGL RERAYGSSGE LITSLPISIP LSTVQPNKLP VSIPLASVVL PSRAERARST
901 PSPVLQPRDP SSTLEKQIGA NAHGAGSRSL ALAPAGFSYA GSVAISGALA GSPASLTPGA
961 EPATLDESSS SGSLFATVGS RSSTPQHPLL LAQPRNSLPA SPAHQLSSSP RLGGAAQGPL
1021 PEASKGDLPS DSGFSDPESE AKRRIVFTIT TGAGSAKQSP SSKHSPLTAS ARGDCVPSHG
1081 QDSRRRGRRK RASAGTPSLS AGVSPKRRAL PSVAGLFTQP SGSPLNLNSM VSNINQPLEI
1141 TAISSPETSL KSSPVPYQDH DQPPVLKKER PLSQTNGAHY SPLTSDEEPG SEDEPSSARI
1201 ERKIATISLE SKSPPKTLEN GGGLAGRKPA PAGEPVNSSK WKSTFSPISD IGLAKSADSP
1261 LQASSALSQN SLFTFRPALE EPSADAKLAA HPRKGFPGSL SGADGLSPGT NPANGCTFGG
1321 GLAADLSLHS FSDGASLPHK GPEAAGLSSP LSFPSQRGKE GSDANPFLSK RQLDGLAGLK
1381 GEGSRGKEAG EGGLPLCGPT DKTPLLSGKA AKARDREVDL KNGHNLFISA AAVPPGSLLS
1441 GPGLAPAASS AGGAASSAQT HRSFLGPFPP GPQFALGPMS LQANLGSVAG SSVLQSLFSS
1501 VPAAAGLVHV SSAATRLTNS HAMGSFSGVA GGTVGGNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DOT1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- testis: 49 nTPM
- cerebellum: 22 nTPM
- bone marrow: 21 nTPM
- kidney: 17 nTPM
- lung: 17 nTPM
- small intestine: 16 nTPM
Single-cell type
- neutrophils: 140 nCPM
- monocytes: 111 nCPM
- renal connecting tubule cells: 101 nCPM
- cone photoreceptor cells: 79 nCPM
- esophageal apical cells: 74 nCPM
- renal collecting duct intercalated cells: 71 nCPM
Immune cell
- eosinophil: 0.8 nTPM
- NK-cell: 0.7 nTPM
- MAIT T-cell: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- myeloid DC: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- cerebellum: 30 nTPM
- white matter: 29 nTPM
- cerebral cortex: 28 nTPM
- thalamus: 26 nTPM
- basal ganglia: 26 nTPM
- medulla oblongata: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DOT1L.
Disease | AllUniProt
Conditions DOT1L is implicated in, by any mechanism.
- Nil-Deshwar neurodevelopmental syndrome (NDNS) MIM:621265
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 354 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nil-Deshwar neurodevelopmental syndrome
- Inborn genetic diseases
- DOT1L-related condition
- Colon adenocarcinoma
Disease | ImmuneIEDB
Conditions an epitope on DOT1L was assayed in.
- glioblastoma T cell
- colonic benign neoplasm T cell
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.72
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage checkpoint signaling
- DNA repair
- gene expression
- methylation
- positive regulation of transcription by RNA polymerase II
- regulation of receptor signaling pathway via JAK-STAT
- regulation of transcription regulatory region DNA binding
- sodium ion transport
- subtelomeric heterochromatin formation
- telomere organization
Molecular functions
- DNA binding
- histone H3 methyltransferase activity
- histone methyltransferase activity
- nucleic acid binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription coactivator activity
- histone H3K79 methyltransferase activity
- histone H3K79 trimethyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Histone H3-K79 methyltransferase, metazoa
- Histone-lysine N-methyltransferase DOT1 domain
- Histone H3-K79 methyltransferase
- Histone methylation protein DOT1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DOT1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DOT1L as an antibody target. Whether an autoantibody or antibody against DOT1L could matter depends on whether native DOT1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DOT1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DOT1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...